Sun Pharma gets Rs 1.11 crore tax demand
The company has received an order from the Joint Commissioner, CGST and Central Excise, passed under the GST Act, raising a demand of Rs 1,11,60,156, imposing a penalty of Rs 11,16,016 and interest as applicable, Sun Pharmaceutical Industries said in a regulatory filing.
Sun Pharmaceutical Industries Ltd on Monday said it has received a tax demand of over Rs 1.11 crore from authorities over disallowed input tax credit.
The company has received an order from the Joint Commissioner, CGST and Central Excise, passed under the GST Act, raising a demand of Rs 1,11,60,156, imposing a penalty of Rs 11,16,016 and interest as applicable, Sun Pharmaceutical Industries said in a regulatory filing.
The reason for the order is disallowed input tax credit on account of inadmissible transitional credit, it added. "There is no material impact on financial, operation or other activities of the company," the filing said.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SBI Green Rupee Deposit 2222 Days vs Canara Bank Green Deposit 2222 Days FD: What Rs 7 lakh and Rs 15 lakh investments will give to general and senior citizens; know here
Highest Senior Citizen FD rates: See what major banks like SBI, PNB, Canara Bank, HDFC Bank, BoB and ICICI Bank are providing on special fixed deposits
Top 7 Large Cap Mutual Funds With Highest SIP Returns in 3 Years: Rs 23,456 monthly SIP investment in No. 1 fund is now worth Rs 14,78,099
Top 7 Small Cap Mutual Funds With Highest SIP Returns in 1 Year: Rs 33,333 monthly SIP investment in No 1 fund has zoomed to Rs 4,93,155
09:07 PM IST